Viral Vector
Sarepta’s rAAVrh74 Viral Vector Receives FDA Platform Technology Designation for Gene Therapy
Sarepta Therapeutics; FDA; platform technology designation; rAAVrh74 viral vector; gene therapy; SRP-9003; limb-girdle muscular dystrophy; rare diseases
BMS to close Illinois site as part of cell therapy manufacturing consolidation
Bristol Myers Squibb, viral vector production, Libertyville Illinois, manufacturing consolidation, Novartis acquisition, cell therapy, cost cuts
Thermo Fisher Scientific Continues Workforce Reduction with 300 Layoffs in Massachusetts
Thermo Fisher Scientific, layoffs, Massachusetts, viral vector production, workforce reduction, biotechnology industry, cost-cutting measures
Thermo Fisher Announces 160 Layoffs in Massachusetts as Part of Viral Vector Overhaul
Thermo Fisher, layoffs, Massachusetts, viral vector, biotechnology, restructuring
Revolutionizing Medicine: The Evolution and Future of Cell and Gene Therapy Manufacturing
Cell therapy manufacturing, gene therapy manufacturing, biomanufacturing, advanced therapies, CAR-T cell therapy, stem cell therapy, viral vectors, bioreactors, automation, scale-up, regulatory compliance, personalized medicine.